These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7927851)

  • 1. Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
    Lacarelle B; Pisano P; Gauthier T; Villard PH; Guder F; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):127-30. PubMed ID: 7927851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.
    Gauthier T; Lacarelle B; Marre F; Villard PH; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):131-4. PubMed ID: 7927852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Favereau JP; Gay R
    Int J Biomed Comput; 1994 Jun; 36(1-2):135-7. PubMed ID: 7927853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.
    Garraffo R; Iliadis A; Cano JP; Dellamonica P; Lapalus P
    J Pharm Sci; 1989 Sep; 78(9):753-7. PubMed ID: 2585270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic parameters for Bayesian monitoring of amikacin therapy in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Gay C; Favereau JP; Gay R
    Eur J Clin Pharmacol; 1992; 43(4):435-6. PubMed ID: 1451727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.
    Lacarelle B; Granthil C; Manelli JC; Bruder N; Francois G; Cano JP
    Ther Drug Monit; 1987 Jun; 9(2):154-60. PubMed ID: 3617153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.
    Iliadis A; Brown AC; Huggins ML
    Comput Methods Programs Biomed; 1992 Aug; 38(4):227-39. PubMed ID: 1473342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.
    Chrystyn H; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1987 Sep; 24(3):301-7. PubMed ID: 3663446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of amikacin in critically ill patients.
    Bressolle F; Gouby A; Martinez JM; Joubert P; Saissi G; Guillaud R; Gomeni R
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1682-9. PubMed ID: 8807062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic Systems.
    Zaera S; Hermida J; Tutor JC
    Ther Drug Monit; 2002 Dec; 24(6):696-700. PubMed ID: 12451284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel Bayesian method for individualizing theophylline dosage.
    Stein U; Oellerich M; Sybrecht GW; Schneider B
    J Clin Chem Clin Biochem; 1988 Jun; 26(6):405-14. PubMed ID: 3411295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach.
    Bolon M; Bastien O; Flamens C; Paulus S; Salord F; Boulieu R
    J Pharm Pharmacol; 2003 Jun; 55(6):765-71. PubMed ID: 12841936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing.
    Ryan AC; Carland JE; McLeay RC; Lau C; Marriott DJE; Day RO; Stocker SL
    Br J Clin Pharmacol; 2021 Mar; 87(3):1422-1431. PubMed ID: 32881037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm.
    Debord J; Pessis C; Voultoury JC; Marquet P; Lotfi H; Merle L; Lachâtre G
    Fundam Clin Pharmacol; 1995; 9(1):57-61. PubMed ID: 7768489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of amikacin in a Korean clinical population.
    Jang SB; Lee YJ; Park MS; Song YG; Kim JH; Kim HK; Ahn BS; Park K
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):371-81. PubMed ID: 21612744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women.
    Matsuki S; Kotegawa T; Tsutsumi K; Nakamura K; Nakano S
    J Clin Pharmacol; 1999 Dec; 39(12):1256-62. PubMed ID: 10586391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.